MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Healthcare Medical Devices

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

TSXV:MIR - Post by User

MedMira Inc

Bullboard Posts

Comment by Park1on Feb 27, 2015 12:51pm

47 Views

Post# 23472552

RE:PPO

Maybe because the market cap for MIR is over 26 mill and they get a couple hundred Thousands of dollars of sales a quarter?. The Money coming in and the money going out, MIR is way over priced. Two ways to solve 1. Do a R/S and let the price go back to where it came from. 2. Have sales generate millions during a quarter.

Bullboard Posts

POET increases production capacity to meet AI demand